285 related articles for article (PubMed ID: 21777345)
1. Transient hypoxia-inducible factor activation in rat renal ablation and reduced fibrosis with L-mimosine.
Yu X; Fang Y; Ding X; Liu H; Zhu J; Zou J; Xu X; Zhong Y
Nephrology (Carlton); 2012 Jan; 17(1):58-67. PubMed ID: 21777345
[TBL] [Abstract][Full Text] [Related]
2. The balance of beneficial and deleterious effects of hypoxia-inducible factor activation by prolyl hydroxylase inhibitor in rat remnant kidney depends on the timing of administration.
Yu X; Fang Y; Liu H; Zhu J; Zou J; Xu X; Jiang S; Ding X
Nephrol Dial Transplant; 2012 Aug; 27(8):3110-9. PubMed ID: 22399494
[TBL] [Abstract][Full Text] [Related]
3. miR-29c is downregulated in renal interstitial fibrosis in humans and rats and restored by HIF-α activation.
Fang Y; Yu X; Liu Y; Kriegel AJ; Heng Y; Xu X; Liang M; Ding X
Am J Physiol Renal Physiol; 2013 May; 304(10):F1274-82. PubMed ID: 23467423
[TBL] [Abstract][Full Text] [Related]
4. Activation of hypoxia-inducible factor attenuates renal injury in rat remnant kidney.
Song YR; You SJ; Lee YM; Chin HJ; Chae DW; Oh YK; Joo KW; Han JS; Na KY
Nephrol Dial Transplant; 2010 Jan; 25(1):77-85. PubMed ID: 19737871
[TBL] [Abstract][Full Text] [Related]
5. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
Lim CS; Kiriakidis S; Paleolog EM; Davies AH
J Vasc Surg; 2012 May; 55(5):1427-39. PubMed ID: 22277691
[TBL] [Abstract][Full Text] [Related]
6. The protective effect of prolyl-hydroxylase inhibition against renal ischaemia requires application prior to ischaemia but is superior to EPO treatment.
Wang Z; Schley G; Türkoglu G; Burzlaff N; Amann KU; Willam C; Eckardt KU; Bernhardt WM
Nephrol Dial Transplant; 2012 Mar; 27(3):929-36. PubMed ID: 21742784
[TBL] [Abstract][Full Text] [Related]
7. The hypoxia-inducible factor-α prolyl hydroxylase inhibitor FG4592 ameliorates renal fibrosis by inducing the H3K9 demethylase JMJD1A.
Ike T; Doi S; Nakashima A; Sasaki K; Ishiuchi N; Asano T; Masaki T
Am J Physiol Renal Physiol; 2022 Nov; 323(5):F539-F552. PubMed ID: 36074918
[TBL] [Abstract][Full Text] [Related]
8. Curcumin provides potential protection against the activation of hypoxia and prolyl 4-hydroxylase inhibitors on prostate-specific antigen expression in human prostate carcinoma cells.
Chung LC; Tsui KH; Feng TH; Lee SL; Chang PL; Juang HH
Mol Nutr Food Res; 2011 Nov; 55(11):1666-76. PubMed ID: 21936051
[TBL] [Abstract][Full Text] [Related]
9. HIF-1alpha-targeted pathways are activated by heat acclimation and contribute to acclimation-ischemic cross-tolerance in the heart.
Maloyan A; Eli-Berchoer L; Semenza GL; Gerstenblith G; Stern MD; Horowitz M
Physiol Genomics; 2005 Sep; 23(1):79-88. PubMed ID: 16046617
[TBL] [Abstract][Full Text] [Related]
10. Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
Knowles HJ; Tian YM; Mole DR; Harris AL
Circ Res; 2004 Jul; 95(2):162-9. PubMed ID: 15192023
[TBL] [Abstract][Full Text] [Related]
11. Ang-1 gene therapy inhibits hypoxia-inducible factor-1alpha (HIF-1alpha)-prolyl-4-hydroxylase-2, stabilizes HIF-1alpha expression, and normalizes immature vasculature in db/db mice.
Chen JX; Stinnett A
Diabetes; 2008 Dec; 57(12):3335-43. PubMed ID: 18835934
[TBL] [Abstract][Full Text] [Related]
12. L-Mimosine blocks cell proliferation via upregulation of B-cell translocation gene 2 and N-myc downstream regulated gene 1 in prostate carcinoma cells.
Chung LC; Tsui KH; Feng TH; Lee SL; Chang PL; Juang HH
Am J Physiol Cell Physiol; 2012 Feb; 302(4):C676-85. PubMed ID: 22116304
[TBL] [Abstract][Full Text] [Related]
13. Activation of the hypoxia-inducible factor-pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors.
Warnecke C; Griethe W; Weidemann A; Jürgensen JS; Willam C; Bachmann S; Ivashchenko Y; Wagner I; Frei U; Wiesener M; Eckardt KU
FASEB J; 2003 Jun; 17(9):1186-8. PubMed ID: 12709400
[TBL] [Abstract][Full Text] [Related]
14. Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys.
Rosenberger C; Mandriota S; Jürgensen JS; Wiesener MS; Hörstrup JH; Frei U; Ratcliffe PJ; Maxwell PH; Bachmann S; Eckardt KU
J Am Soc Nephrol; 2002 Jul; 13(7):1721-32. PubMed ID: 12089367
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia inducible factor stabilization improves defective ischemia-induced angiogenesis in a rodent model of chronic kidney disease.
Schellinger IN; Cordasic N; Panesar J; Buchholz B; Jacobi J; Hartner A; Klanke B; Jakubiczka-Smorag J; Burzlaff N; Heinze E; Warnecke C; Raaz U; Willam C; Tsao PS; Eckardt KU; Amann K; Hilgers KF
Kidney Int; 2017 Mar; 91(3):616-627. PubMed ID: 27927598
[TBL] [Abstract][Full Text] [Related]
16. Expression and actions of HIF prolyl-4-hydroxylase in the rat kidneys.
Li N; Yi F; Sundy CM; Chen L; Hilliker ML; Donley DK; Muldoon DB; Li PL
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F207-16. PubMed ID: 16885149
[TBL] [Abstract][Full Text] [Related]
17. Short-term effects of pharmacologic HIF stabilization on vasoactive and cytotrophic factors in developing mouse brain.
Schneider C; Krischke G; Keller S; Walkinshaw G; Arend M; Rascher W; Gassmann M; Trollmann R
Brain Res; 2009 Jul; 1280():43-51. PubMed ID: 19450570
[TBL] [Abstract][Full Text] [Related]
18. Role of impaired peritubular capillary and hypoxia in progressive interstitial fibrosis after 56 subtotal nephrectomy of rats.
Zhang B; Liang X; Shi W; Ye Z; He C; Hu X; Liu S
Nephrology (Carlton); 2005 Aug; 10(4):351-7. PubMed ID: 16109081
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of the sensory and regulatory pathways controlling cellular iron metabolism in unilateral obstructive nephropathy.
Votava JA; Reese SR; Deck KM; Nizzi CP; Anderson SA; Djamali A; Eisenstein RS
Am J Physiol Renal Physiol; 2022 Jan; 322(1):F89-F103. PubMed ID: 34843656
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia inducible factor-1α mediates the profibrotic effect of albumin in renal tubular cells.
Hu J; Wang W; Zhang F; Li PL; Boini KM; Yi F; Li N
Sci Rep; 2017 Nov; 7(1):15878. PubMed ID: 29158549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
